These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29181493)

  • 21. Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential.
    Abushakra S; Porsteinsson A; Scheltens P; Sadowsky C; Vellas B; Cummings J; Gauthier S; Hey JA; Power A; Wang P; Shen L; Tolar M
    J Prev Alzheimers Dis; 2017; 4(3):149-156. PubMed ID: 29182706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction.
    Watterson DM; Grum-Tokars VL; Roy SM; Schavocky JP; Bradaric BD; Bachstetter AD; Xing B; Dimayuga E; Saeed F; Zhang H; Staniszewski A; Pelletier JC; Minasov G; Anderson WF; Arancio O; Van Eldik LJ
    PLoS One; 2013; 8(6):e66226. PubMed ID: 23840427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of the basal forebrain cholinergic dysfunction in pathogenesis of declarative memory disorder in Alzheimer's disease].
    Mukhin VN
    Ross Fiziol Zh Im I M Sechenova; 2013 Jun; 99(6):674-81. PubMed ID: 24459876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination.
    van Wijk N; Broersen LM; de Wilde MC; Hageman RJ; Groenendijk M; Sijben JW; Kamphuis PJ
    J Alzheimers Dis; 2014; 38(3):459-79. PubMed ID: 23985420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p38alpha mitogen-activated protein kinase as a central nervous system drug discovery target.
    Borders AS; de Almeida L; Van Eldik LJ; Watterson DM
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S12. PubMed ID: 19090985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do cholinesterase inhibitors slow progression of Alzheimer's disease?
    Farlow MR
    Int J Clin Pract Suppl; 2002 Jun; (127):37-44. PubMed ID: 12139366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting p38 MAPK pathway for the treatment of Alzheimer's disease.
    Munoz L; Ammit AJ
    Neuropharmacology; 2010 Mar; 58(3):561-8. PubMed ID: 19951717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment.
    Molinuevo JL; Berthier ML; Rami L
    Arch Gerontol Geriatr; 2011; 52(1):18-22. PubMed ID: 19948364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b.
    Huang W; Li Z; Zhao L; Zhao W
    Biomed Pharmacother; 2017 Aug; 92():46-57. PubMed ID: 28528185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J
    Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case for a non-transgenic animal model of Alzheimer's disease.
    Stéphan A; Phillips AG
    Genes Brain Behav; 2005 Apr; 4(3):157-72. PubMed ID: 15810904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.
    Luo J; Lee SH; VandeVrede L; Qin Z; Piyankarage S; Tavassoli E; Asghodom RT; Ben Aissa M; Fà M; Arancio O; Yue L; Pepperberg DR; Thatcher GR
    BMC Neurosci; 2015 Oct; 16():67. PubMed ID: 26480871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human beta-amyloid in a murine model of neuroinflammation.
    Craft JM; Van Eldik LJ; Zasadzki M; Hu W; Watterson DM
    J Mol Neurosci; 2004; 24(1):115-22. PubMed ID: 15314259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacologic treatment of Alzheimer's disease: a guide for the general psychiatrist.
    Flint AJ; van Reekum R
    Can J Psychiatry; 1998 Sep; 43(7):689-97. PubMed ID: 9773218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.
    Li L; Xu S; Liu L; Feng R; Gong Y; Zhao X; Li J; Cai J; Feng N; Wang L; Wang X; Peng Y
    J Alzheimers Dis; 2017; 56(4):1403-1417. PubMed ID: 28157092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits.
    Hu W; Ralay Ranaivo H; Roy SM; Behanna HA; Wing LK; Munoz L; Guo L; Van Eldik LJ; Watterson DM
    Bioorg Med Chem Lett; 2007 Jan; 17(2):414-8. PubMed ID: 17079143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
    Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
    J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Auditory cortical function during verbal episodic memory encoding in Alzheimer's disease.
    Dhanjal NS; Warren JE; Patel MC; Wise RJ
    Ann Neurol; 2013 Feb; 73(2):294-302. PubMed ID: 23281111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.